Literature DB >> 23697939

Epigenetics in the heart: the role of histone modifications in cardiac remodelling.

Asmita Tingare1, Bernard Thienpont, H Llewelyn Roderick.   

Abstract

Understanding the molecular mechanisms underlying cardiac development and growth has been a longstanding goal for developing therapies for cardiovascular disorders. The heart adapts to a rise in its required output by an increase in muscle mass and alteration in the expression of a large number of genes. However, persistent stress diminishes the plasticity of the heart, consequently resulting in its maladaptive growth, termed pathological hypertrophy. Recent developments suggest that the concomitant genome-wide remodelling of the gene expression programme is largely driven through epigenetic mechanisms such as post-translational histone modifications and DNA methylation. In the last few years, the distinct functions of histone modifications and of the enzymes catalysing their formation have begun to be elucidated in processes important for cardiac development, disease and cardiomyocyte proliferation. The present review explores how repressive histone modifications, in particular methylation of H3K9 (histone H3 Lys9), govern aspects of cardiac biology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23697939     DOI: 10.1042/BST20130012

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  10 in total

Review 1.  The programming of cardiovascular disease.

Authors:  K L Thornburg
Journal:  J Dev Orig Health Dis       Date:  2015-07-15       Impact factor: 2.401

Review 2.  Epigenetics of the failing heart.

Authors:  José Marín-García; Alexander T Akhmedov
Journal:  Heart Fail Rev       Date:  2015-07       Impact factor: 4.214

3.  Histone modifications interact with DNA methylation at the GATA4 promoter during differentiation of mesenchymal stem cells into cardiomyocyte-like cells.

Authors:  Hao Xu; Qin Yi; Chunmei Yang; Yue Wang; Jie Tian; Jing Zhu
Journal:  Cell Prolif       Date:  2016-04-26       Impact factor: 6.831

4.  Role of extracellular histones in the cardiomyopathy of sepsis.

Authors:  Miriam Kalbitz; Jamison J Grailer; Fatemeh Fattahi; Lawrence Jajou; Todd J Herron; Katherine F Campbell; Firas S Zetoune; Markus Bosmann; J Vidya Sarma; Markus Huber-Lang; Florian Gebhard; Randall Loaiza; Hector H Valdivia; José Jalife; Mark W Russell; Peter A Ward
Journal:  FASEB J       Date:  2015-02-13       Impact factor: 5.191

Review 5.  Histone methylations in heart development, congenital and adult heart diseases.

Authors:  Qing-Jun Zhang; Zhi-Ping Liu
Journal:  Epigenomics       Date:  2015       Impact factor: 4.778

Review 6.  Histone deacetylases in modulating cardiac disease and their clinical translational and therapeutic implications.

Authors:  Zhengke Wang; Yu Tina Zhao; Ting C Zhao
Journal:  Exp Biol Med (Maywood)       Date:  2020-07-29

7.  Epigenetic switch at atp2a2 and myh7 gene promoters in pressure overload-induced heart failure.

Authors:  Tiziana Angrisano; Gabriele Giacomo Schiattarella; Simona Keller; Gianluigi Pironti; Ermanno Florio; Fabio Magliulo; Roberta Bottino; Raffaela Pero; Francesca Lembo; Enrico Vittorio Avvedimento; Giovanni Esposito; Bruno Trimarco; Lorenzo Chiariotti; Cinzia Perrino
Journal:  PLoS One       Date:  2014-09-02       Impact factor: 3.240

Review 8.  Targeting Epigenetics and Non-coding RNAs in Myocardial Infarction: From Mechanisms to Therapeutics.

Authors:  Jinhong Chen; Zhichao Liu; Li Ma; Shengwei Gao; Huanjie Fu; Can Wang; Anmin Lu; Baohe Wang; Xufang Gu
Journal:  Front Genet       Date:  2021-12-20       Impact factor: 4.599

9.  NSD2 promotes ventricular remodelling mediated by the regulation of H3K36me2.

Authors:  Xue-Liang Zhou; Rong-Rong Zhu; Xia Wu; Hua Xu; Yun-Yun Li; Qi-Rong Xu; Sheng Liu; Huang Huang; Xinping Xu; Li Wan; Qi-Cai Wu; Ji-Chun Liu
Journal:  J Cell Mol Med       Date:  2018-10-18       Impact factor: 5.310

Review 10.  Genetics and Epigenetics of Atrial Fibrillation.

Authors:  Estefanía Lozano-Velasco; Diego Franco; Amelia Aranega; Houria Daimi
Journal:  Int J Mol Sci       Date:  2020-08-10       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.